Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy

Circulation

Volumn 92, Issue 1, 1995, Pages 15-23

  Yabe, Takahiro ^b   Mitsunami, Kenichi ^b   Inubushi, Toshiro ^a   Kinoshita, Masahiko ^b  

^a Molec Neurobiology Research Center   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Exercise; Magnetic resonance imaging; Myocardium; Phosphates; Thallium

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; THALLIUM 201;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART MUSCLE METABOLISM; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PHOSPHATE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; CORONARY DISEASE; FEMALE; HUMAN; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGE; MYOCARDIUM; PHOSPHOCREATINE; SUPPORT, NON-U.S. GOV'T; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0029034236     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.92.1.15     Document Type: Article

References (36)

1. Weiss RG, Bottomley PA, Hardy CJ, Gerstenblith G. Regional myocardial metabolism of high energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med. 1990;323:1593-1600.
2. Ingwall JS. Phosphorus nuclear magnetic resonance spectroscopy of cardiac and skeletal muscle. Am J Physiol. 1982;242(Heart Circ Physio1 11):H729-H744.
3. Higgins CB, Saeed M, Wendland M, Chew WM. Magnetic resonance spectroscopy of the heart: overview of studies in animals and man. Invest Radiol. 1989;24:962-968.
4. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: altered cardiac high-energy phosphate metabolism in heart failure. Circulation. 1992;86:1810-1818.
5. Luney DJE, den Hollander JA, Evanochko WT, Johnson LL, Pohost GM. Spectroscopy of human myocardial scar. Proc Soc Magn Reson Med, 12th Annual Scientific Meeting. 1993;3:1091. Abstract.
6. 31P magnetic resonance spectroscopy during hand-grip exercise. Circulation. 1994;89:1709-1716.
7. Bottomley PA, Hardy CJ, Roemer PB. Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance. Magn Reson Med. 1990;14:425-434.
8. 31P nuclear magnetic resonance spectroscopy in patients with old myocardial infarction. Jpn Circ J. 1992;56:614-619.
9. 201Tl SPECT imaging in patients with old myocardial infarction. Proc Soc Magn Reson Med, 12th Annual Scientific Meeting. 1993;3:1090. Abstract.
10. Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L, Maddahi J, Germano G. Separate acquisition rest thallium-201/ stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol. 1993;22:1455-1464.
11. Chua T, Kiat H, Germano G, Maurer G, van Train K, Friedman J, Berman D. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability: correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol. 1994;23:1107-1114.
12. 201Tl defects. Circulation. 1992; 86:1357-1369.
13. Lenkinski RE, Allman T, Scheiner JD, Deming SN. An automated iterative algorithm for the quantitative analysis of in vivo spectra based on the simplex optimization method. Magn Reson Med. 1989;10:338-348.
14. Ernst RR, Anderson WA. Application of Fourier transform spectroscopy to magnetic resonance. Rev Sci Instrum. 1966;37:93-102.
15. Bottomley PA, Weiss RG, Hardy CJ, Baumgartner WA. Myocardial high-energy phosphate metabolism and allograft rejection in patients with heart transplants. Radiology. 1991;181:67-75.
16. Schaefer S, Gober JR, Schwalz GG, Twieg DB, Weiner MW, Massie B. In vivo phosphorus-31 spectroscopic imaging in patients with global myocardial disease. Am J Cardiol. 1990;65:1154-1161.
17. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J. 1991;122:795-801.
18. 31P magnetic resonance spectroscopy. Br Heart J. 1991;65:25-30.
19. Schaefer S. Clinical application of cardiac spectroscopy. In: Schaefer S, Balaban RS, eds. Cardiovascular Magnetic Resonance Spectroscopy. Boston, Mass: Kluwer Academic Publishers; 1993: 215-224.
20. Parker JO, West RO, Case RB, Chiong MA. Temporal relationships of myocardial lactate metabolism, left ventricular function and S-T segment depression during angina precipitated by exercise. Circulation. 1969;40:97-111.
21. Mudge GH Jr, Mills RM Jr, Taegtmeyer H, Gorlin R, Lesch M. Alterations of myocardial amino acid metabolism in chronic ischemic heart disease. J Clin Invest. 1976;58:1185-1192.
22. McDonald KM, Yoshiyama M, Francis GS, Ugurbil K, Cohn JN, Zhang J. Myocardial bioenergetic abnormalities in a canine model of left ventricular dysfunction. J Am Coll Cardiol. 1994;23:786-793.
23. Schaefer S, Schwartz GG, Wisneski JA, Trocha SD, Christoph I, Steinman SK, Garcia J, Massie BM, Weiner MW. Response of high-energy phosphates and lactate release during prolonged regional ischemia in vivo. Circulation. 1992;85:342-349.
24. Pohost GM, Zir LM, Moore RH, McKusick KA, Guiney TE, Beller GA. Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation. 1977;55:294-302.
25. Gutman J, Berman DS, Freeman M, Rosanski A, Maddahi J, Waxman A, Swan HJ. Time to completed redistribution of thallium-201 in exercise myocardial scintigraphy: relationship to the degree of coronary artery stenosis. Am Heart J. 1983;106:989-995.
26. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation. 1993;87:1-20.
27. Liu P, Kiess MC, Okada RD, Block PC, Strauss HW, Pohost GW, Boucher CA. The persistent defect on exercise thallium imaging and its fate after myocardial revascularization: does it represent scar or ischemia? Am Heart J. 1985;110:996-1001.
28. Gibson RS, Watson DD, Taylor GJ, Crosby IK, Wellons HL, Holt ND, Beller GA. Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy. J Am Coll Cardiol. 1983;1: 804-815.
29. Schelbert HR, Phelps ME, Huang SC, MacDonald NS, Hansen H, Selin C, Kuhl DE. N-13 ammonia as an indicator of myocardial blood flow. Circulation. 1981;63:1259-1272.
30. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps ME, Schelbert H. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med. 1986;314:884-888.
31. Tamaki N, Yonekura Y, Yamashita K, Saji H, Magata Y, Senda M, Konishi Y, Hirata K, Ban T, Konishi J. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol. 1989;64:860-865.
32. Vanoverschelde JLJ, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, Bol A, Melin JA. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation. 1993; 87:1513-1523.
33. Smart SC, Swada S, Ryan T, Segar D, Atherton L, Berkovitz K, Bourdillon PDV, Feigenbaum H. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation. 1993;88:405-415.
34. 31P spin-echo studies of myocardial ATP and phosphocreatine. J Magn Reson. 1984;57:221-227.
35. Balaban RS. NMR spectroscopy of the heart: part 1. Concepts Magn Reson. 1989;1:15-26.
36. 31P spectroscopy: the definition of localized volumes, dealing with saturation and the technique-dependence of quantification. NMR Biomed. 1989;2:284-289.